Skip to main content

Table 4 Studies on the role of CGRP in neuropathic pain

From: Calcitonin gene-related peptide and pain: a systematic review

Study

Objectives

Reported pain as part of phenotype

Method and sample size

Source of CGRP

Results

Duration of the investigated condition

Correlation between CGRP level and pain

Albrecht, 2006 [1]

Investigate CGRP expression in skin from amputated extremity affected by CRPS

CRPS after amputation in upper and lower limbs

Skin tissue from 2 patients and 5 controls

Tissue biopsies

(skin)

Loss of CGRP expression in CRPS patients

NR

NR

Attal, 2016 [2]

Determine CGRP levels in peripheral neuropathic pain patients after treatment with botulinum toxin A

Peripheral neuropathic pain, mixed group

ELISA of biopsy from 23 patients with active treatment and 17 patients with placebo treatment at week 1 and 4 after study start

Skin

No change in CGRP levels at week 4 compared to week 1. Average pain score was not changed either

NR

None

Awawdeh, 2002 [3]

Investigate presence of CGRP in the gingival crevicular fluid of teeth diagnosed with pain of pulpal origin

Tooth pain

Gingival crevicular fluid from a painful and non-painful site from 54 patients undergoing pulpectomy. 1 week after fluid was collected from 21 patients

Gingival crevicular fluid

No difference in CGRP-levels between painful tooth compared to the contralateral control tooth

NR

No clear association between CGRP-levels and dental pain

Boras, 2010 [4]

Determine saliva and serum CGRP levels in patients with BMS

Burning mouth syndrome

Saliva and serum from 26 patients and 22 controls

Saliva and serum

No difference between patients and controls

NR

NR

Birklein, 2001 [5]

Test contribution of neuropeptide release to pathophysiology of CRPS

CRPS in upper or lower limbs

Serum CGRP concentrations were measured in 19 patients on the affected (n = 19) side and non-affected side (n = 13) before and 9 months after therapy (n = 9). Comparison with controls (n = 16)

Blood

(serum)

Increased CGRP levels in CRPS patients.

No difference in CGRP levels in blood taken from affected versus non-affected side.

After therapy – normalization of CGRP levels compared to healthy controls

Mean 29 weeks (range: 2 to 188 weeks)

No correlation between CGRP-levels and pain

Chavarría-Bolanos, 2014 [6]

Determine CGRP-levels in dental pulp tissue samples from 8 patients subjected to undergo controlled orthodontic intrusive forces

Tooth pain

Human premolar dental pulp tissue was extracted from 8 patients, and 8 controls

Tissue biopsies

(dental pulp)

No differences in CGRP levels between the two groups

24 h

NR

Hou, 2011 [7]

Determine whether CGRP-IL is increased among epidermal keratinocytes in PHN and diabetes

PHN and small fiber neuropathy

Punch biopsies from 5 patients with PHN from painful areas, 5 patients with diabetes (biopsies from feet) and 11 controls

Tissue biopsies

(skin)

Increased CGRP-levels in keratinocytes from PHN patients compared to controls

NR

CGRP levels were higher in painful skin areas compared to non-painful locations

Kalliomäki, 2011 [8]

Investigate structural and functional differences between patients with and without chronic pain following nerve injury

Hand pain due to nerve injury

Skin biopsies from 21 patients with pain and 9 controls without pain. All participants required hand surgery

Tissue biopsies

(skin)

No difference in CGRP-staining between patients and controls

>1 year

No significant difference between pain and non-pain patients

Lindqvist. 2000 [9]

Examine CGRP expression in painful Morton’s neuroma patients

Forefoot Morton’s neuroma

11 nerve biopsies from 8 patients and 4 controls

Nerve biopsies

Increased levels of CGRP-IR nerve fibers compared to controls

NR

NR

Schinkel, 2009 [10]

Compare systemic inflammatory mediators in patients with CRPS I with controls

CRPS in the upper limb

Blood samples were obtained from 22 patients. 12 patients had chronic CRPS and 10 patients had acute CRPS. Patients were compared to 8 controls

Blood

(plasma)

CGRP-levels were lower in chronic CRPS patients, compared to controls

Acute: < 6 months

Chronic: > 6 months

NR

Zidverc-Trajkovic, 2009 [11]

Determine saliva CGRP levels in patients with BMS

Burning mouth syndrome

Saliva from 78 patients and 16 healthy controls

Saliva

Inconclusive, CGRP levels were non-significantly decreased in comparison to controls

At least 6 months

NR

  1. BMS Burning mouth syndrome, CRPS Complex regional pain syndrome, CSF Cerebrospinal fluid